Compare TMDX & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | COTY |
|---|---|---|
| Founded | 1998 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.0B |
| IPO Year | 2019 | 2013 |
| Metric | TMDX | COTY |
|---|---|---|
| Price | $136.41 | $3.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 17 |
| Target Price | ★ $133.00 | $5.48 |
| AVG Volume (30 Days) | 835.5K | ★ 5.8M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 170.70 | N/A |
| EPS | ★ 2.54 | N/A |
| Revenue | $566,354,000.00 | ★ $5,798,600,000.00 |
| Revenue This Year | $38.84 | $1.90 |
| Revenue Next Year | $20.43 | $2.53 |
| P/E Ratio | $53.83 | ★ N/A |
| Revenue Growth | ★ 41.20 | N/A |
| 52 Week Low | $55.00 | $3.12 |
| 52 Week High | $156.00 | $8.04 |
| Indicator | TMDX | COTY |
|---|---|---|
| Relative Strength Index (RSI) | 54.31 | 46.76 |
| Support Level | $133.50 | $3.35 |
| Resistance Level | $156.00 | $3.50 |
| Average True Range (ATR) | 8.50 | 0.11 |
| MACD | 0.41 | 0.04 |
| Stochastic Oscillator | 55.98 | 86.25 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.